1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Senior Center Permanent Improvement Project (PIP) Emergency Grant is sponsored by South Carolina Department on Aging (SCDOA). This grant program is intended to support multipurpose senior centers in South Carolina to function as focal points in their communities, providing activities, services, and programs for active older adults with an emphasis on health and wellness, education, and social engagement.
Applications for emergency grants will be accepted.
Get alerted about grants like this
Save a search for “South Carolina Department on Aging (SCDOA)” or related topics and get emailed when new opportunities appear.
Search similar grants →According to the current listing, eligibility includes: Multipurpose senior centers in South Carolina that meet the National Council on Aging's Multipurpose Senior Center Standards. Confirm the full requirements in the official notice before applying.
Applications for Senior Center Permanent Improvement Project (PIP) Emergency Grant are due June 30, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Senior Center Permanent Improvement Project (PIP) Emergency Grant is funded by South Carolina Department on Aging (SCDOA). Verify program details on the funder's official page before applying.
This opportunity targets applicants in South Carolina. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Seven research teams will run the first clinical trials aimed at extending human healthspan under ARPA-H PROSPR contracts worth up to $144M. The milestone-based contract model breaks every convention of federal biomedical funding.
Read articleARPA-H PROSPR program funds seven research teams up to $144M to develop the first clinical trials targeting biological aging itself, testing rapamycin analogs, semaglutide, and retrotransposon inhibitors.
Read articleARPA-H awarded $144M across 7 research teams to run the first clinical trials treating aging as a condition — not a disease. How PROSPR reshapes longevity funding and what grant seekers in biotech, academia, and health tech should know.
Read article